Attached files
| file | filename |
|---|---|
| 10-Q - Vilacto Bio Inc. | g8370.htm |
| EX-31 - Vilacto Bio Inc. | ex31-2.htm |
| EX-31.1 - Vilacto Bio Inc. | ex31-1.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of ZLATO INC. (the "Company") on Form 10-Q for the period ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Dana Gallovicova, Chief Executive and Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Dana Gallovicova
|
||
|
Date: February 17, 2017
|
Dana Gallovicova
|
|
|
President, CEO and Secretary Treasurer
|
||
|
Principal Executive, Financial and Accounting Officer
|
||